Literature DB >> 21572361

Multiple intraosseous inflammatory myofibroblastic tumors presenting with an aggressive clinical course: case report.

Yasuo Sasagawa1, Takuya Akai, Shoutarou Itou, Hideaki Iizuka.   

Abstract

BACKGROUND AND IMPORTANCE: The authors report a rare case of multiple intraosseous inflammatory myofibroblastic tumors presenting with an aggressive clinical course. CLINICAL
PRESENTATION: A 60-year-old man presented with a 3-month history of headache and 2 weeks of jaw pain. Magnetic resonance imaging showed a homogeneously enhancing mass in the right parietal bone with subcutaneous and intracranial invasion. Bone scintigraphy revealed 4 intraosseous lesions involving the cranium, mandible, ischium, and calcaneum. After admission, the patient showed left hemiparesis and seizures caused by rapid intracranial tumor extension. The cranial and mandible tumors were resected. Histopathological examinations of both specimens revealed myofibroblastic spindle cell proliferation with inflammatory cell infiltration, and a diagnosis of inflammatory myofibroblastic tumor was made. Two days postoperatively, the patient presented with a high fever and disturbance of consciousness with swelling of the subcutaneous tissues of the head and mandibular lesions. Magnetic resonance imaging revealed a massive intracranial extension of the tumor. Corticosteroid therapy induced remarkable shrinkage of all lesions, and relief from symptoms was obtained. Radiotherapy was then performed for residual tumors.
CONCLUSION: Multiple intraosseous inflammatory myofibroblastic tumors of the bone are very uncommon and may mimic malignant tumors. It is important to recognize that this entity can occur in the cranium and as multiple bony lesions. The recommended treatment is complete surgical resection with adjuvant steroid treatment. Considering the aggressive nature of this entity, additional chemo- and/or radiotherapy may be warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21572361     DOI: 10.1227/NEU.0b013e318223b651

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

1.  Whether inflammatory myofibroblastic tumor of the thigh relapses after surgical excision?

Authors:  Hao Liu; Jun Lin; Peng Yang; Hao Shen; Huilin Yang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Recurrent inflammatory myofibroblastic tumor of the inguinal region: A case report and review of the literature.

Authors:  Tian Zhang; Yawei Yuan; Chen Ren; Shasha DU; Jiarong Chen; Quanquan Sun; Zhengjun Liu
Journal:  Oncol Lett       Date:  2015-05-29       Impact factor: 2.967

Review 3.  Sinonasal Inflammatory Myofibroblastic Tumor with Anaplastic Lymphoma Kinase 1 Rearrangement: Case Study and Literature Review.

Authors:  Ghizlene Lahlou; Marion Classe; Michel Wassef; Pierre-Alexandre Just; Nicolas Le Clerc; Philippe Herman; Benjamin Verillaud
Journal:  Head Neck Pathol       Date:  2016-07-21

4.  A case of recurrent pulmonary inflammatory myofibroblastic tumor with aggressive metastasis after complete resection.

Authors:  Chae Ho Moon; Jong Ho Yoon; Geon Wook Kang; Seong Hyeon Lee; Jeong Su Baek; Seo Yun Kim; Hye-Ryoun Kim; Cheol Hyeon Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-10-29

5.  Intraosseous inflammatory myofibroblastic tumor in the mandible: a rare pathologic case report.

Authors:  Dale E Stringer; Chad N Allen; Katina Nguyen; Rahul Tandon
Journal:  Case Rep Surg       Date:  2014-09-01

6.  Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report.

Authors:  Yoko Tateishi; Koji Okudela; Shigeo Kawai; Takehisa Suzuki; Shigeaki Umeda; Mai Matsumura; Mitomu Kioi; Kenichi Ohashi
Journal:  Diagn Pathol       Date:  2016-11-15       Impact factor: 2.644

7.  Inflammatory myofibroblastic tumour of the skull base.

Authors:  Jean-Philippe Maire; Sandrine Eimer; François San Galli; Valérie Franco-Vidal; Sigolène Galland-Girodet; Aymeri Huchet; Vincent Darrouzet
Journal:  Case Rep Otolaryngol       Date:  2013-02-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.